William L. Macias
2023
In 2023, William L. Macias earned a total compensation of $1.9M as Chief Medical Officer at Immunovant, a 72% decrease compared to previous year.
Compensation breakdown
| Bonus | $210,000 |
|---|---|
| Option Awards | $636,078 |
| Salary | $500,000 |
| Stock Awards | $562,952 |
| Other | $9,876 |
| Total | $1,918,906 |
Macias received $636.1K in option awards, accounting for 33% of the total pay in 2023.
Macias also received $210K in bonus, $500K in salary, $563K in stock awards and $9.9K in other compensation.
Rankings
In 2023, William L. Macias' compensation ranked 557th out of 2,983 executives tracked by ExecPay. In other words, Macias earned more than 81.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 557 out of 2,983 | 81st |
Division Manufacturing | 315 out of 1,637 | 81st |
Major group Chemicals And Allied Products | 218 out of 906 | 76th |
Industry group Drugs | 215 out of 869 | 75th |
Industry Biological Products, Except Diagnostic Substances | 75 out of 211 | 65th |
Source: SEC filing on June 26, 2023.
Macias' colleagues
We found two more compensation records of executives who worked with William L. Macias at Immunovant in 2023.